| Date | Title | Description |
| 13.07.2026 | Sleep Is the Stress Test Health AI Is Failing | Colin Lawlor, CEO of Sleep.ai
Health AI is only as good as the data it’s built on. And when it comes to sleep, much of that data is fundamentally flawed.
As health and wellness apps race to integrate sleep tracking and AI-driven coaching, t... |
| 07.07.2026 | M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M | What You Should Know
Global health technology leader ResMed has announced a definitive agreement to sell its MatrixCare business to healthcare-exclusive private equity firm Frazier Healthcare Partners for $450M.
The corporate divestiture ex... |
| 09.06.2026 | Owaves Adds IP and Business Development Veteran Brian Niznik to Advisory Board | Seasoned executive brings three decades of licensing, strategic alliance, and healthtech commercialization expertise to circadian wellness platform
ENCINITAS, Calif., June 9, 2026 /PRNewswire-PRWeb/ -- Owaves, Inc., the creator of BodyClock... |
| 29.05.2026 | ŌURA Launches Oura Ring 5: Embedding Live Blood Pressure Signals and GLP-1 Tracking Into Wearable Tech
Beyond Awareness to Action: Oura Ring 5 Unveils Proactive Health Radar and Connected Care Pathway... | What You Should Know
Wearable technology leader ŌURA has officially launched Oura Ring 5, re-engineering its mechanical and electrical architecture to create a device that is 40% smaller than its predecessor.
Moving past passive metrics, th... |
| 11.05.2026 |
Jim Cramer says today’s market is punishing stocks harder than 1999 | Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer said today’s market resembles 1999 in its narrow leadership, but argued one major difference stands out: Wall Street is punishing stocks even more aggressively than during the dot-com era... |
| 04.12.2025 | Tech Meets Sleep: How Smart CPAP Machines and Modern Nasal Masks Work Together for Better Therapy Outcomes | Share
Share
Share
Share
Email
The New Era of Sleep Technology
The humble bedroom has become a data centre. From smart thermostats that optimise room temperature to wearables that track REM cycles, health-tech has infiltrated our most intima... |
| 02.12.2025 | LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea | LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effective December 1. Blaise reports to Vladimir Ma... |
| 25.09.2025 | How AirMini Can Help You Stick to Therapy While Camping | Share
Share
Share
Share
Email
Camping can be an out-of-reach activity to many users of such devices like sleep apnea, especially when it comes to carrying CPAP gear into the wild. Large machines, requirement of power, and little packing spa... |
| 08.08.2025 | 9 VCs, die jetzt Millionen in heiße deutsche Startups investieren | Die Kapitaltöpfe vieler deutscher Investoren füllen sich wieder! In den vergangenen Wochen und Monaten haben sowohl junge als auch etablierte Venture-Capital-Unternehmen wieder neue Fonds aufgelegt – darunter auch Project A Ventures (325 Mi... |
| 07.08.2025 | ClimateTech Innovator Tanso Secures €12M to Revolutionize Industrial Sustainability | Tanso, a leading ClimateTech firm, recently secured €12 million in Series A funding. This investment propels its AI-driven platform for environmental management and compliance. Amid escalating regulatory pressures and buyer demands, Tanso e... |
| 05.08.2025 | German VC fund Smart Infrastructure Ventures launches €30 million SIVentures II Fund to support early-stage startups | Following the success of its first fund, Leipzig-based VC fund Smart Infrastructure Ventures has announced the launch of its €30 million fund, SIVentures II to further invest in early-stage startups focused on innovative technologies in AI,... |
| 05.08.2025 | Smart Infrastructure Ventures launches €30M SIVentures II Fund | Smart Infrastructure Ventures, a Leipzig-based venture capital firm, has launched its second fund, SIVentures II, with €30 million in capital, following the success of its first fund. The company invests in early-stage startups developing i... |
| 05.08.2025 | ClimateTech Tanso sammelt 12 Millionen ein | Im #DealMonitor für den 5. August werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-Ar... |
| 21.04.2025 | Resmed Names Salli Schwartz as Chief Investor Relations Officer | Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment community
SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technol... |
| 02.04.2025 | Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025 | SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23, 2025, after the New York Stoc... |
| 02.04.2025 | Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025 | SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23, 2025, after the New York Stoc... |
| 21.03.2025 |
Cramer’s week ahead: Don’t buy Twilio | Monday - Friday, 6:00 - 7:00 PM ET
It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Resmed: ”...I like the stock.”
Twilio: “I t... |
| 19.03.2025 | New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer | Largest ever meta-analysis on the long-term benefits of CPAP therapy, published in The Lancet Respiratory Medicine, found that in people with sleep apnea, CPAP therapy lowered the overall chance of dying by 37% and the chance of heart-relat... |
| 07.02.2025 | TrueFoundry's Rise: Fueling AI Deployment with Fresh Capital | In the bustling world of artificial intelligence, TrueFoundry is carving its niche. The startup, born from the minds of former Meta engineers, has just secured a hefty $19 million investment from Intel Capital. This funding is not just a fi... |
| 07.02.2025 | TrueFoundry's $19 Million Leap: Redefining AI Deployment | In the fast-paced world of artificial intelligence, TrueFoundry has emerged as a beacon of innovation. The San Francisco-based startup recently secured $19 million in Series A funding, led by Intel Capital. This financial boost is not just ... |
| 07.02.2025 | AI startups Truefoundry, Cognida collect Series A cheques | (From left) TrueFoundry's Nikunj Bajaj, Anuraag Gutgutia and Abhishek Choudhary
Artificial intelligence startups Truefoundry and Cognida.ai have bagged investments in separate Series A funding rounds as investors bet on growing demand for A... |
| 07.02.2025 | AI Scaling Startup TrueFoundry Secures USD 19 Mn from Intel Capital, Eniac Ventures, and Peak XV With the fresh funding, TrueFoundry aims to develop a universal AI deployment platform, expand its team... | TrueFoundry, an AI deployment and scaling platform, has raised USD 19 million in Series A funding led by Intel Capital. The round also saw participation from existing investors Eniac Ventures and Peak XV's Surge, alongside new investor Jump... |
| 06.02.2025 | TrueFoundry: $19 Million (Series A) Raised To Transform AI Deployment | TrueFoundry—a leading AI deployment and scaling platform—announced it raised $19 million in Series A funding, led by Intel Capital. Existing investors Eniac Ventures and Peak XV’s Surge (formerly Sequoia Capital India and SEA) participated,... |
| 06.02.2025 | TrueFoundry Secures $19 Million Series A Funding to Transform AI Deployment at Scale Powered by their Agent on Autopilot | With funding led by Intel Capital, TrueFoundry empowers enterprises to build and deploy AI applications with unparalleled efficiency and governance
Related Posts
Cognida.ai Secures $15 Million Series A from Nexus Venture Partners to Redefin... |
| 06.02.2025 | Intel Capital выделяет TrueFoundry 19 млн долларов на финансирование масштабного внедрения AI | TrueFoundry, стартап, созданный группой бывших инженеров Meta* для помощи предприятиям в масштабном развертывании систем искусственного интеллекта, привлек 19 миллионов долларов новых инвестиций под руководством Intel Capital.
С появлением ... |
| 12.01.2025 | CES 2025: The Global Stage for Innovation, Connecting the World, Creating the Future | Where Technology Meets Humanity to Create Extraordinary Possibilities
LAS VEGAS, Jan. 12, 2025 /PRNewswire/ -- CES® 2025, the most powerful tech event in the world, welcomed over 141,000 attendees from around the globe. With more than 4500 ... |
| 09.01.2025 | ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025 | SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2025 on Thursday, January 30, 2025, after the New York Sto... |
| 09.01.2025 | ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025 | SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2025 on Thursday, January 30, 2025, after the New York Sto... |
| 06.01.2025 | ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference | SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 43rd Annual J.P. Morgan Healthcar... |
| 23.12.2024 | S&P 500, Dow dip in choppy trading at start of holiday-shortened week | S&P 500, Dow dip in choppy trading at start of holiday-shortened week
By Medha Singh and Purvi AgarwalDecember 23, 20244:42 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Traders work on th... |
| 17.12.2024 | Apple’s Latest Moves: Innovations, Travels, and Rumors | Apple is a titan in the tech world. Each week, it rolls out updates, unveils new products, and engages with global markets. The recent week was no exception. From the launch of iOS 18.2 to Tim Cook’s international travels, Apple’s presence ... |
| 16.12.2024 | Apple Pro Weekly News (09.12 – 15.12.24) | На неделе вышла новая система iOS 18.2, а теперь стало известно какие уязвимости там закрыли и что за проблемы испытывает компания при работе над iOS 19. Где побывал Тим Кук и какой высокий гость пришёл в лондонский офис компании? Кто запус... |
| 03.12.2024 | Loftie: Sleep Technology Company Raises Funding From Supermoon Capital | Loftie, an innovative sleep technology company dedicated to helping people rest, relax, and recharge, announced it has closed on a lead investment from Supermoon Capital as part of a $2 million funding round to accelerate its expansion in d... |
| 05.11.2024 | ResMed Announces Participation in the UBS Global Healthcare Conference | SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the UBS Global... |
| 24.10.2024 | ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025 | Year-over-year revenue grows 11%, operating profit up 34%, non-GAAP operating profit up 27% Operating cash flow of $326 million
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.co... |
| 24.10.2024 | ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025 | Year-over-year revenue grows 11%, operating profit up 34%, non-GAAP operating profit up 27%Operating cash flow of $326 million
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com... |
| 03.10.2024 | ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024 | SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the New York Stoc... |
| 03.10.2024 | Revealed: The top 10 companies claiming the most R&D tax expenditure in Australia | Source: SmartCompany article-article-body
Tech unicorn Atlassian reported $200 million in research and development (R&D) expenditure in 2021-2022, topping the Australian Taxation Office’s first public list of entities claiming the R&... |
| 10.09.2024 | ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange | Learn more about ResMed’s 2030 strategy to accelerate growthJoin in person or via virtual webcast
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) will host an investor day on Monday, September 30, 2024, beginning ... |
| 22.08.2024 | ResMed partners with BillingPlatform to automate billing process | ResMed has chosen BillingPlatform to automate its billing and subscription management processes. This move aims to replace manual methods and decrease the risk of revenue leakage. ResMed, known for its medical products that focus on respira... |
| 15.08.2024 | ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board | DelOrefice is the Chief Financial Officer at BD, one of the largest global MedTech companies in the world
Board appointment brings over 30 years of strategic and operational finance expertise
SAN DIEGO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Res... |
| 15.08.2024 | ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board | DelOrefice is the Chief Financial Officer at BD, one of the largest global MedTech companies in the world
Board appointment brings over 30 years of strategic and operational finance expertise
SAN DIEGO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Res... |
| 01.08.2024 | ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024 | Year-over-year revenue grows 9%, operating profit up 38%, non-GAAP operating profit up 30%Operating cash flow of $440 millionQuarterly dividend increases 10% to $0.53 per shareCompany to host an Investor Day on September 30, 2024
Note: A we... |
| 19.07.2024 | VARON Enters CPAP and BiPAP Machine Market with Feature-Rich "Sunny Grand" Series | SEATTLE, July 19, 2024 /PRNewswire/ -- VARON, a leading provider of oxygen concentrator solutions, is thrilled to announce the launch of its new line of CPAP (continuous positive airway pressure) and BiPAP (bilevel positive airway pressure)... |
| 10.06.2024 | PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia | SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Aca... |
| 10.06.2024 | PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia | ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSA
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -... |
| 17.05.2024 | What works best for insomnia and sleep apnoea? Light therapy, sleeping pills, CPAP machine or surgery? | Listen to this article
What works best for insomnia and sleep apnoea? Light therapy, sleeping pills, CPAP machine or surgery?
1 min
New: You can now listen to articles.
Sorry, the audio is unavailable right now. Please try again later.
This... |
| 26.04.2024 | Don't just track your steps. Here are 4 health metrics to monitor on your smartwatch, according to doctors. | From smart wearables like the Apple Watch or Garmin trackers to the celebrity-sported Oura ring and trendy WHOOP strap, health tech has come a long way from just tracking your steps.
"There's lots of different metrics now that we can b... |
| 18.04.2024 | Eli Lilly's weight-loss drug Zepbound could treat sleep apnea | Eli Lilly said Wednesday that its weight-loss drug Zepbound improved symptoms in two late-stage trials of patients with obstructive sleep apnea.
Why it matters: If treating sleep apnea ultimately earns an FDA green light, it could expand in... |
| 04.04.2024 | ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024 | SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2024 on Thursday, April 25, 2024, after the New York Stock... |
| 21.03.2024 | SINGAPORE'S "HUSTLE CULTURE" TAKES ITS TOLL: THE AIR STATION AND RESMED LAUNCH INITIATIVE TO ADDRESS WORK-INDUCED SLEEP ISSUES | Global survey reveals that 39% of Singaporeans grapple with sleep, impacting health and productivity.
The Air Station and ResMed's upcoming joint initiative, "Discover Your Sleep Superpowers," aims to empower Singaporeans with fre... |
| 15.03.2024 | Wake Up Call for India: Is a Well-rested Future in the Cards for Indians, as Alarmingly Only 27% are Sleeping Well Every Night | New Delhi, Delhi, India
54% Indian respondents have not consulted with a medical professional about their sleep difficulties.
Work related stress is the top cause of disrupted sleep in India, with 42% Indians stating it keeps them up at nig... |
| 13.03.2024 | Global Sleep Apnea Devices Market Set to Surpass US$ 9.95 Billion by 2030, Driven by Rising Prevalence and Healthcare Innovations | - |
| 06.03.2024 | Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask | - |
| 12.01.2024 |
ResMed CPAP masks recall is Class I | The AirTouch N20, one of the devices affected by the corrective action. [Image from ResMed]The FDA announced that ResMed’s voluntary recall of millions of CPAP mask magnets is now Class I, the agency’s most serious level.
Last month, ResMed... |
| 06.07.2023 | ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023 | /EIN News/ -- SAN DIEGO, July 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on Thursday, August 3, 2023, after the ... |
| 05.07.2023 | ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software | Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatment Diagnostic management platform is upstream of and complementary to Re... |
| 05.06.2023 | ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference | /EIN News/ -- SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthca... |
| 25.05.2023 | 3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023 | France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSA
Germany’s Michael Arzt presented new evidence that treating CSA with ASV... |
| 02.01.2023 | ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference | /EIN News/ -- SAN DIEGO, Jan. 02, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023, beg... |
| 18.11.2022 | ResMed Appoints Sandeep Gulati as General Manager, South Asia | Delhi, India
ResMed, a global leader in digital health, connected sleep and respiratory care is reinforcing its commitment to India by strengthening its leadership with the appointment of Sandeep Gulati as General Manager, South Asia. In hi... |
| 27.10.2022 | ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023 | Year-over-year revenue grows 5%, operating profit up 5%, non-GAAP operating profit up 4%
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSW... |
| 13.10.2022 | ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022 | SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2023 on Thursday, October 27, 2022, after the New York Stoc... |
| 07.09.2022 | ResMed Announces Participation in the Bank of America Global Healthcare Conference | SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference on Wednesday, Septembe... |
| 06.09.2022 | ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference | SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conferenc... |
| 04.09.2022 | Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports | New prevalence figure 22–126% higher than previous estimatesPrevalence expected to reach 592 million by 2050Researchers urge global action on smoking cessation and air pollution reduction
BARCELONA, Spain, Sept. 04, 2022 (GLOBE NEWSWIRE) --... |
| 26.08.2022 | ResMed Announces AwakenYourBest Campaign with Baba Sehgal to Emphasize on Sleeping Well | Delhi, India
ResMed, a global leader in digital health, connected sleep and respiratory care devices announced the launch of a new campaign #AwakenYourBest to create awareness about sleep and sleeping disorders that need requisite attention... |
| 15.08.2022 | ResMed Buys German Firm | ResMed has acquired mementor, a Leipzig, Germany-based private firm that’s developed a digital therapy for insomnia delivered via an app.
Katrin Pucknat President ResMed Germany The deal was completed Aug. 1. Financial terms of the transact... |
| 11.08.2022 | ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022 | Year-over-year revenue grows 4%, operating profit up 6%, non-GAAP operating profit up 4%Quarterly dividend increases 5% to $0.44 per share
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investo... |
| 02.08.2022 | ResMed Acquires Digital Therapeutics App for Insomnia
| What You Should Know:
somnio closes a gap in care for insomnia patients and complements ResMed’s efforts to increase both awareness of this disease—which impacts 1 in 10 Germans—and access to effective home treatments, while laying the foun... |
| 02.08.2022 | ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio | Acquisition lays foundation to build ResMed’s digital sleep medicine portfolio in Germany
somnio digital health application focused on improving sleep in patients with diagnosed insomnia, filling care gap and providing alternative to prevai... |
| 14.07.2022 | ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022 | SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on Thursday, August 11, 2022, after the New York Stoc... |
| 28.06.2022 | ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care | Blaise is a medtech industry thought leader with over 25 years’ experience
A board member of MedTech Europe since 2020; President of the Snitem, France’s premier medtech associationPromotion effective July 1
SAN DIEGO, June 28, 2022 (GLOBE ... |
| 20.06.2022 | $1B Acquisition for ResMed | ResMed (NYSE: RMD) announced on Tuesday (June 14) that it has entered an agreement to buy MEDIFOX DAN, a privately held German company specializing in out-of-hospital software solutions, for $1 billion.
Mick Farrell CEO ResMed ResMed said i... |
| 14.06.2022 | ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions | Acquisition creates a global leader in out-of-hospital software solutionsAccelerates ResMed’s SaaS strategy by extending ResMed’s position as a leading U.S. provider of SaaS solutions in out-of-hospital care settings into GermanyMEDIFOX DAN... |
| 14.06.2022 | ResMed Acquires MEDIFOX DAN for $1B, Expands Healthcare SaaS Business | What You Should Know:
– ResMed acquires MEDIFOX DAN, a German leader in software solutions for home health, nursing home, and outpatient therapy providers, for $1 billion. This acquisition marks ResMed’s largest SaaS acquisition to date and... |
| 14.06.2022 | ResMed buys German digital healthcare platform MEDIFOX DAN for $1 billion | Software and services investor Hg has sold German digital care platform MEDIFOX DAN to San Diego-based ResMed in a transaction valuing the business at an enterprise value of around $1 billion. The new acquisition will allow ResMed to expand... |
| 01.06.2022 | ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference | SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the William Blair Growth Stock Conference on Wednesday, June 8, 2022, beginning at... |
| 25.05.2022 | ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference | SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bernstein Strategic Decisions Conference on Wednesday, June 1, 2022, ... |
| 18.05.2022 | Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study | 2–3 hours of nightly PAP use shows health benefits at 3 months, 1 year, and 2 years
Health benefits significantly increase by use hour/night, up to 7 hours
SAN FRANCISCO, May 18, 2022 (GLOBE NEWSWIRE) -- Sleep apnea sufferers can gain healt... |
| 05.05.2022 | ResMed Announces Leadership Change | SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President, Sleep and Respiratory Care, has informed ResMed that he has accepted a new position and is leaving the company, effec... |
| 27.04.2022 | ResMed Announces Participation in the 24th Annual Macquarie Australia Conference | SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Tuesday, May 3, 2022, beginning at approxi... |
| 07.04.2022 | ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022 | SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2022 on Thursday, April 28, 2022, after the New York Stock... |
| 14.03.2022 | ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day | Surveys found pandemic-related stress and anxiety are the most cited reasons keeping people up at nightQuality and quantity of sleep have benefitted from remote working, and many are concerned waking up will be difficult as they return to a... |
| 10.03.2022 | ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference | SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022, beg... |
| 16.02.2022 | ResMed Announces Participation in the Citi Healthcare Conference | SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Citi Healthcare Conference on Wednesday, February 23, 2022, ... |
| 01.02.2022 | ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer | Tyagi brings over 25 years’ IT and leadership experience from ADP, American Express, Amazon, Microsoft, and IBM
Current CTO and SaaS President Bobby Ghoshal now transitions to SaaS full-time
SAN DIEGO, Feb. 01, 2022 (GLOBE NEWSWIRE) -- ResM... |
| 28.01.2022 | ResMed : Announces Results for the Second Quarter of FY2022 | For personal use only
For investors For media
Amy Wakeham Jayme Rubenstein
+1 858-836-5000 +1 858-836-6798
[email protected] [email protected]
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022
Year-over-yearr... |
| 28.01.2022 | ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022 | Year-over-year revenue grows 12%, operating profit up 12%, non-GAAP operating profit up 5%
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
SAN DIEGO, Jan. 27, 2022 (GLOBE NEW... |
| 27.01.2022 | ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022 | Year-over-year revenue grows 12%, operating profit up 12%, non-GAAP operating profit up 5%
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
SAN DIEGO, Jan. 27, 2022 (GLOBE NEW... |
| 07.01.2022 | ResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022 | SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2022 on Thursday, January 27, 2022, after the New York Sto... |
| 06.01.2022 | ResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022 | SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2022 on Thursday, January 27, 2022, after the New York Sto... |
| 03.01.2022 | ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference | SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, beginning at app... |
| 03.01.2022 | ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference | SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, beginning at app... |
| 30.12.2021 | ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference | SAN DIEGO, Dec. 30, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on Thursday, January 6, 202... |
| 30.12.2021 | ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference | SAN DIEGO, Dec. 30, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on Thursday, January 6, 202... |
| 22.12.2021 | Chapters Health Home Care Named a 2021 HHCAHPS Honors Recipient | “To be named as a HHCAHPS Honors Recipient is a humbling reminder of how proud we are of our Chapters Health Home Care team, said Dean Forman,” chief operating officer for Chapters Health System.
NEW PORT RICHEY, Fla. (PRWEB) December 22, 2... |
| 19.11.2021 | ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors | Tan is vice president and managing director of Microsoft’s Health and Life Science R&D Hernandez is Google’s head of clinical research, health economics, and outcomes researchBoth leaders’ digital health experience at world-leading tech... |
| 09.11.2021 | ResMed Posts Stellar Q1 Results | Mick Farrell is ResMed's CEO. During Q1, the company introduced the AirSense 11 in the U.S. San Diego-based ResMed (NASDAQ: RMD) posted strong quarterly results last week, beating analysts’ estimates even as ongoing supply chain bottlenecks... |
| 03.11.2021 | ResMed Announces Participation in the Credit Suisse 30th Annual Healthcare Conference | SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Credit Suisse 30th Annual Healthcare Conference on Wednesday... |
